Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03866239
Title A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DNK

Facility Status City State Zip Country Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
UCLA Cancer Center Santa Monica California 90404 United States Details
Stanford Comprehensive Cancer Center Stanford California 94305 United States Details
Yale University New Haven Connecticut 06510 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Duke Cancer Center Durham North Carolina 27710 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Rigshospitalet; Fase 1 Enhed - Onkologi København Ø 2100 Denmark Details
Centre Leon Berard; Departement Oncologie Medicale Lyon 69373 France Details
Institut Gustave Roussy Villejuif 94805 France Details
Hospital Univ Vall d'Hebron; Servicio de Oncologia Sant Andreu de La Barca Barcelona 08740 Spain Details
Clinica Universitaria de Navarra; Servicio de Oncologia Pamplona Navarra 31008 Spain Details
START Madrid-FJD, Hospital Fundacion Jimenez Diaz Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field